![C. Boyd Clarke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
C. Boyd Clarke
Président chez
FluGen, Inc.
Profil
C.
Boyd Clarke is currently the Executive Chairman at FluGen, Inc. He previously held positions as the President & Chief Executive Officer at U.S.
Bioscience, Inc. from 1996 to 1999, Chairman & Chief Executive Officer at Neose Technologies, Inc. from 2002 to 2007, President & Chief Executive Officer at MedImmune Vaccines, Inc. from 1999 to 2002, Chairman at QLT, Inc. from 2003 to 2012, Chairman at Aldeyra Therapeutics, Inc. from 2013 to 2017, and Chairman at Mersana Therapeutics, Inc. He also served as the Executive Chairman at Takeda Vaccines (Montana), Inc. and as a Director at Biotechnology Innovation Organization, Palkion, Inc., Melinta Subsidiary Corp., and LigoCyte Pharmaceuticals, Inc. Additionally, he was a Director at NovaDigm Therapeutics, Inc. in 2010.
Prior to these roles, he worked as the Vice President-Merck Vaccines at Merck & Co., Inc. from 1977 to 1996.
Mr. Clarke received his undergraduate and graduate degrees from the University of Calgary.
Postes actifs de C. Boyd Clarke
| Sociétés | Poste | Début |
|---|---|---|
FluGen, Inc.
 FluGen, Inc. BiotechnologyHealth Technology Develops and produces influenza vaccines | Président | 05/09/2017 |
Anciens postes connus de C. Boyd Clarke
| Sociétés | Poste | Fin |
|---|---|---|
| ALDEYRA THERAPEUTICS, INC. | Président | 08/06/2017 |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Président | 04/06/2012 |
NovaDigm Therapeutics, Inc.
 NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines to prevent fungal and bacterial infections | Directeur/Membre du Conseil | 22/12/2010 |
Neose Technologies, Inc.
 Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic protein drugs | Président | 01/05/2007 |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology Develops, manufactures and markets live vaccines | President | 01/03/2002 |
Formation de C. Boyd Clarke
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
U.S. Bioscience, Inc.
 U.S. Bioscience, Inc. BiotechnologyHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Commercial Services |
Neose Technologies, Inc.
Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic protein drugs | Health Technology |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology Develops, manufactures and markets live vaccines | Health Technology |
Aldeyra Therapeutics, Inc.
 Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Palkion, Inc.
 Palkion, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for the treatment of anemia | Health Technology |
FluGen, Inc.
FluGen, Inc. BiotechnologyHealth Technology Develops and produces influenza vaccines | Health Technology |
University of Calgary
 University of Calgary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
LigoCyte Pharmaceuticals, Inc.
 LigoCyte Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Developed vaccines and monoclonal antibody therapeutics | Health Technology |
NovaDigm Therapeutics, Inc.
NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines to prevent fungal and bacterial infections | Health Technology |
Takeda Vaccines (Montana), Inc.
 Takeda Vaccines (Montana), Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on the development of vaccines that prevent human infectious diseases | Health Technology |
